Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
Clinical Drug Investigation|August 14, 2016
Deferiprone-Induced Agranulocytosis : A Critical Review of Five Rechallenged CasesR Loebstein, O Diav-Citrin, G Atanackovic, et al.Canadian Family Physician Medecin De Famille Canadien|May 20, 1998
Managing exposure to chickenpox during pregnancy. New programG Inocencion, R Loebstein, A Lalkin, et al.The Journal of Allergy and Clinical Immunology|November 7, 1999
Pregnancy outcome after gestational exposure to terfenadine: A multicenter, prospective controlled studyR Loebstein, A Lalkin, A Addis, et al.Diabetes Care|August 14, 1998
Diabetic nephropathy in hypertransfused patients with beta-thalassemia. The role of oxidative stressR Loebstein, D C Lehotay, X Luo, et al.European Journal of Clinical Pharmacology|June 19, 2017
Voriconazole-induced QT prolongation among hemato-oncologic patients: clinical characteristics and risk factorsI Gueta, R Loebstein, N Markovits, et al.Acta Paediatrica (Oslo, Norway : 1992)|November 21, 2018
Voriconazole-induced QTc prolongation in a paediatric populationY Pasternak, N Shechter, R Loebstein, et al.Alimentary Pharmacology & Therapeutics|July 10, 2003
Bioavailability of oral vs. subcutaneous low-dose methotrexate in patients with Crohn's diseaseD Kurnik, R Loebstein, E Fishbein, et al.American Journal of Obstetrics and Gynecology|October 3, 1998
The safety of omeprazole during pregnancy: a multicenter prospective controlled studyA Lalkin, R Loebstein, A Addis, et al.Clinical Pharmacology and Therapeutics|August 15, 2001
Interindividual variability in sensitivity to warfarin--Nature or nurture?R Loebstein, H Yonath, D Peleg, et al.Journal of Clinical Pharmacology|May 11, 1999
Risk factors for long-term outcome of ifosfamide-induced nephrotoxicity in childrenR Loebstein, G Atanackovic, R Bishai, et al.Pageof 3